Optibiotix Health Share Discussion Threads

[m4rtinu] 09/10/2018 09:27

Mr Smith, whilst it might be correct to state that the deal in today's RNS will give no immediate revenue to OPTI, I think that is being a bit pedantic.

I agree OPTI are testing our patience for revenues to come on stream but the RNS also reminds us that:

"More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks."

So, accepting that some of these deals may be close to a year old now, the revenue should start to appear.

I notice you qualify your comment in post #164

"if and when the company does do I may take a different view..."

I couldn't find the question/ comment you were referring to, but this suggests to me you have OPTI on your watch list. And, if I was you, I wouldn't want the share price to rise whilst waiting for funds to arrive.

I would welcome your comments on the above. MU

[tightfist] 09/10/2018 09:27

Hi Parob; thanks for the updated, growing, global partner list; in amongst the market turmoil we may need to be reminded about the prospects/enablers for the PATIENT investor! The health issues we all may face are not magically going away.......

[siennadelekat21] 09/10/2018 08:52

Rayrac, you may have missed it, but a couple of Companies in the Pharma world have already made a deal for Optis LP-LDL product... obviously this will take some time to come to fruition, but considering one of these companies has earmarked the best part of £50m for the project, I would say you're way off base mate. And guess what.....While we're waiting for that to happen, Opti will be generating revenues from a multitude of other sources as well.... pretty slick eh? Sienna : )

[judijudi] 09/10/2018 08:43

Show us the oil and your balance sheet at UGOT nowt!!

[rayrac] 09/10/2018 08:36

Of course. But not as cures for, or prevention of obesity, lowering cholesterol or bp! If LPL did that, then it would be a pharmaceutical subscription drug, with royalties flowing at it.

Show us the royalty stream, that’s all we ask, cash to the bottom line.

[suzypink] 09/10/2018 08:27

Exactly the point....so if our strains are in them and available at night street shops opti is earning !!!!!

[rayrac] 09/10/2018 08:19

I can buy most of those companies products off the shelves of retailers eg, Holland and Barrett...an extremely competitive world!

[judijudi] 09/10/2018 08:13

Rayrac,
Are you saying that all these companies signing up every week to do deals with Opti are wasting their money on all the plant set ups, sales force teams etc etc?
Do you not think they will do their own due diligence on Opti products?
Do you think they just sign up for the sake of it after going to this expense?
Stick to UGOT nowt and your tanker counting!
Funny

[parob] 09/10/2018 08:07

Here is the updated list guys:Current and future revenue streams confirmed by RNS so far:- GoFigure- Sacco- HLH BioPharma Vertriebs GmbH - Nutrilinia- Pharmabiota- Galenicum Special Ingredients - Knighton Foods- Cereal Ingredients Inc.- Fine Foods & Pharmaceuticals- Trigen Pharma- Cambridge Commodities - Akums Drugs and Pharma- Seed Health- Morley's - Alfasigma- Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing & distribution.- Unnamed US pharma partner (cholesterol strain)- Bened Biomedical- Unnamed Bulgarian CholBiome distributor - CTC Group- Formulation Creations- US Pharma Lab Inc.Revenue not confirmed by RNS yet:- Tata X 2 (Slimbiome and LPGOS)- Mystery US Slimbiome customer

[rayrac] 09/10/2018 08:05

Does LPL actually work as a product, ie lower cholesterol, bp etc? Or is it just another probiotic add on. As I’ve said before, if it were that good, why does the medical world ignore it!

Income still not there either.

[ramas] 09/10/2018 07:55

With market jitters investors can wait , but it's a safe place for your money and to buy more while the delta closes over time and probably past this time of Marxist fear ... dyor of course

[parob] 09/10/2018 07:53

Market can't keep ignoring all these deals forever. Looking forward to the price catching up with progress when the tide does finally turn (must be close). We went from 65p to 130p last time and that was without any deal announcements!

[best1467] 09/10/2018 07:51

Yes but it’s the right manufacturer to create revenue, another building block in place

[tsmith2] 09/10/2018 07:51

if and when the company does do I may take a different view...all just hype and ramping - followed by confetti

[asterix96] 09/10/2018 07:50

tsmith2 - Into Room 101 (Filtered)

[rastamouse] 09/10/2018 07:50

Show me the money!!

[monkeywench1] 09/10/2018 07:43

Can't wait for the revenues to flow.

[tsmith2] 09/10/2018 07:43

if anyone hasn't twigged out to it just yet - it's a manufacturing agreement, sales value £nil.

[tsmith2] 09/10/2018 07:41

You've got to love this!This agreement gives a strategic access to the world's largest probiotic market, with an estimated retail value of $7.1 billion per annum. The US is one of the largest and fastest growing probiotic markets in the world, with supplements alone accounting for $2.06 billion sales, with a projected 55% growth to $3.3 billion by 2021.If that's not utter PR spin, I don't what is...#bargepole

[nw99] 09/10/2018 07:37

Company continues to have very positive news flows

[parob] 09/10/2018 07:27

They have obviously been working together for a while as they are showcasing the first formulation at SSW just next month!

[parob] 09/10/2018 07:19

US pharma deal - 4th Sept. from RNS:OptiBiotix will be responsible for the manufacture of its Lactobacillus plantarum strain to pharmaceutical drug standards. Today's RNS seems to tie in with that:The US (New Jersey) manufacturing footprint includes a purpose build probiotic manufacturing facility and covers over 100,000 sq ft with Pharmaceutical GMP certification, which offers the possibility to utilise LP(LDL) (R) in pharmaceutical applications.

[parsons4] 09/10/2018 07:10

And so the deals continue !!!

[thebigchap] 09/10/2018 07:06

  Print    ;  Mail a friend

Tuesday 09 October, 2018

OptiBiotix HealthLPLDL® US manufacturing and supply agreement

RNS Number : 3381D

OptiBiotix Health PLC

09 October 2018